Job Cuts Expected Amid Barcelona Hub Uncertainty
AstraZeneca is preparing a workforce reduction in Spain that could significantly impact its Barcelona Global Hub, according to employee representatives and reports from cronicaglobal.elespanol.com. The British-Swedish pharmaceutical company has initiated formal procedures by notifying trade union delegates of its intention to launch a collective dismissal process. The first meeting of the negotiating committee is scheduled for 13 October 2026, marking the start of a 30-day consultation period. While the company has not yet disclosed the number of positions at risk or the affected departments, the potential impact on its Barcelona operations is considered highly likely.
Barcelona Hub: A Major Investment at Stake
The AstraZeneca Global Hub in Barcelona, housed in the Estel building on Avenida Roma, was inaugurated in 2023 as a cornerstone of the company’s international strategy. It currently employs nearly 1,600 professionals across nine floors and 30,000 square metres of renovated space, representing approximately 64% of AstraZeneca’s 2,500 employees in Spain. According to investinspain.org, the hub focuses on clinical development, regulatory affairs, biometrics, IT, digital innovation, and data science, hosting professionals from 62 nationalities. AstraZeneca had committed to investing €1.3 billion in the project by 2027, a sum comparable to the annual R&D investment of Spain’s entire pharmaceutical sector (barcelona.cat). In February 2025, Eurofound recorded AstraZeneca’s announcement of 830 new job creations in Barcelona by the end of that year, with plans to grow the team to 2,000 workers (Eurofound factsheet 202434). This expansion contrasted sharply with the current restructuring plans.
Spain is a powerhouse in clinical research. From here, we will accelerate biomedical innovation supported by technology and artificial intelligence.
, Rick R. Suárez, President of AstraZeneca Spain, investinspain.org The company estimates that each direct job in the biomedical sector generates four indirect roles, meaning the Barcelona hub supports up to 8,000 jobs in total, based on Farmaindustria data cited by barcelona.cat. Internal communications refer to a "dismissal file", avoiding the formal term Employment Regulation File (ERE), but the process is now underway. Employees and local authorities await clarity on the final scope of the proposed cuts following the upcoming negotiations.
Primary sources: barcelona.cat, apps.eurofound.europa.eu. Reported by investinspain.org, economiadigital.es, cronicaglobal.elespanol.com.
